MGMT and neoplasm: Particularly, Chang et al. demonstrated the MGMT promoter methylation status with 83% accuracy and correlated it with specific imaging features such as tumour margins, T1 and FLAIR suppression, presence of necrosis and textural features, and extent of oedema [140].